We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
Cap. Flow
+$86.8M
Cap. Flow %
0.16%
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$86.2M
2
ALC icon
Alcon
ALC
+$81.8M
3
NVDA icon
NVIDIA
NVDA
+$76M
4
GLW icon
Corning
GLW
+$50.4M
5
UNH icon
UnitedHealth
UNH
+$42.3M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$67.4M
2
FDS icon
Factset
FDS
+$62M
3
EEFT icon
Euronet Worldwide
EEFT
+$42.3M
4
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$39.5M
5
OPLN
Openlane
OPLN
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Consumer Discretionary 17.74%
3 Financials 11.65%
4 Healthcare 11.2%
5 Communication Services 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FN icon
601
Fabrinet
FN
$20.1B
– –
-450
Closed -$24K
FOX icon
602
Fox Class B
FOX
$23.9B
– –
-16
Closed -$1K
TDAY
603
USA Today Co
TDAY
$1.06B
– –
-1,891
Closed -$20K
GCO icon
604
Genesco
GCO
$422M
– –
-101,920
Closed -$4.64M
GME icon
605
GameStop
GME
$8.6B
– –
-8,948
Closed -$23K
GNL icon
606
Global Net Lease
GNL
$1.95B
– –
-127
Closed -$2K
GOOD
607
Gladstone Commercial Corp
GOOD
$627M
– –
-1,623
Closed -$34K
HAFC icon
608
Hanmi Financial
HAFC
$946M
– –
-720
Closed -$15K
HAE icon
609
Haemonetics
HAE
$4B
– –
-100,637
Closed -$8.8M
HCA icon
610
HCA Healthcare
HCA
$89.5B
– –
-124
Closed -$16K
HCC icon
611
Warrior Met Coal
HCC
$4.86B
– –
-590
Closed -$18K
HI
612
DELISTED
Hillenbrand
HI
– –
-887
Closed -$37K
HII icon
613
Huntington Ingalls Industries
HII
$12.8B
– –
-128
Closed -$27K
HLF icon
614
Herbalife
HLF
$1.29B
– –
-275
Closed -$15K
HOPE icon
615
Hope Bancorp
HOPE
$1.79B
– –
-1,657
Closed -$22K
HSTM icon
616
HealthStream
HSTM
$840M
– –
-957
Closed -$27K
HWC icon
617
Hancock Whitney
HWC
$6.24B
– –
-143
Closed -$6K
HY icon
618
Hyster-Yale Materials Handling
HY
$665M
– –
-292
Closed -$18K
HYG icon
619
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
– –
-315,773
Closed -$27.3M
IDCC icon
620
InterDigital
IDCC
$8.89B
– –
-298
Closed -$20K
IMMR icon
621
Immersion
IMMR
$252M
– –
-1,611
Closed -$14K
INN
622
Summit Hotel Properties
INN
$700M
– –
-620
Closed -$7K
INTC icon
623
Intel
INTC
$513B
– –
-1,709
Closed -$92K
INVA icon
624
Innoviva
INVA
$1.48B
– –
-923
Closed -$13K
IRTC icon
625
iRhythm Holdings
IRTC
$4.2B
– –
-322,878
Closed -$24.2M
23 24
25
26 27

Similar funds

CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Loomis, Sayles & Company's Q2 2019 Portfolio in Review

As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
  • Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
  • Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
  • Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
  • Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
  • Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.